News

The Microcatheters Market is undergoing rapid expansion, fuelled by the growing adoption of minimally invasive procedures, ...
The global atherectomy devices market is expected to grow at a CAGR of ~8% during the forecast period. The increasing ...
The global health economics and outcomes research services market is expected to grow at a CAGR of ~13% during the forecast ...
DNA Methylation Market OverviewDNA methylation is a biological process in which methyl groups (CH3) are added to the DNA ...
The global neonatal intensive care respiratory devices market is expected to grow at a CAGR of ~6% during the forecast period ...
Kite Pharma will buy Interius BioTherapeutics for $350 million in cash to add an in vivo CAR‑T platform that creates T‑cell ...
Royalty Pharma will pay up to $950 million for a 7 percent royalty in Amgen’s Imdelltra, a breakthrough small cell lung ...
Spinal Implants Material Market OverviewThe global Spinal Implants Material Market is valued at USD 9.8 Million in 2024 and ...
CAL101 is a first-in-class monoclonal antibody targeting S100A4, a damage-associated molecular pattern (DAMP) protein associated with serious and life-threatening fibrotic disordersPhase 2 AURORA ...
Regulatory News:Celyad Oncology (Euronext: CYAD) (“Celyad” or the “Company”), today announced that it has decided to discontinue its research and development (R&D) activities and to implement a ...
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, announces the completion of the first cohort in the clinical Phase I trial evaluating the drug candidate ...
The global ventricular assist devices (VAD) market is projected to grow at a CAGR of ~11% during the forecast period. This growth is primarily driven by the rising prevalence of heart failure, the ...